Study on 99mTc-MAG3 and 99mTc-DMSA renal accumulation using in vitro cellular model

Area of Science:

• Nuclear Medicine
• Renal Physiology
• Radiopharmaceutical Science

Background:

• Technetium-99m mercaptoacetyltriglycine (99mTc-MAG3) and technetium-99m dimercaptosuccinic acid (99mTc-DMSA) are standard renal radiodiagnostics.
• The precise renal transport mechanisms for these agents remain incompletely understood.
• No in vitro studies have directly compared their cellular-level renal uptake.

Purpose of the Study:

• To compare the renal uptake of 99mTc-MAG3 and 99mTc-DMSA.
• To evaluate the roles of active and passive transport in their renal accumulation.
• To investigate these processes at the cellular level using primary rat renal cells.

Main Methods:

• Isolation of primary rat renal cells via two-phase collagenase perfusion.
• In vitro incubation of renal cells with 99mTc-MAG3 and 99mTc-DMSA.
• Assessment of radiopharmaceutical accumulation under conditions with and without inhibition of active transport processes.

Main Results:

• Significant quantitative and qualitative differences observed in cellular accumulation between 99mTc-MAG3 and 99mTc-DMSA.
• 99mTc-MAG3 exhibited several times higher cellular uptake compared to 99mTc-DMSA.
• 99mTc-MAG3 uptake was significantly reduced by inhibiting energy-dependent processes, while 99mTc-DMSA uptake showed minimal energy dependence.

Conclusions:

• 99mTc-MAG3 and 99mTc-DMSA display distinct renal accumulation mechanisms at the cellular level.
• Active, energy-dependent transport significantly contributes to 99mTc-MAG3 renal uptake.
• Passive or less energy-dependent mechanisms are primarily involved in 99mTc-DMSA renal accumulation.